Charles R. Goulding and Preeti Sulibhavi analyze Jamie Dimon’s recent Security & Resiliency Initiative (SRI), which strategically funds US defense and innovation projects.
johnson and johnson
From Pulsed Energy to Printed Anatomy: 3D Printing’s Role in Modern EP
Charles R. Goulding and Andress Bonafe break down how Boston Scientific and Johnson & Johnson’s EP rivalry is fueling explosive PFA growth and a surge in demand for 3D printed cardiac models.
Reinventing Orthopaedics: DePuy Synthes and the Additive Age of MedTech
Charles R. Goulding and Andressa Bonafe examine how Johnson & Johnson’s spin-off of DePuy Synthes sets the stage for a more agile, 3D printing–driven orthopaedics powerhouse ready to redefine surgical innovation.
FDA Greenlights Intuitive Surgical’s DaVinci: A Game-Changer in Soft Tissue Surgery
Charles R. Goulding and Preeti Sulibhavi analyze how the FDA clearance of Intuitive Surgical’s new DaVinci system is set to revolutionize soft tissue robotic surgery.
Uncovering the Benefits of 3D Printing in MedTech
Charles R. Goulding and Preeti Sulibhavi look at the use of 3D printing in five major healthcare companies.
Leveraging 3D Printing with Johnson & Johnson’s Acquisition of Abiomed
Charles R. Goulding and Preeti Sulibhavi suggest increased use of 3D printing Johnson & Johnson.
3D Printing Implications of the Johnson & Johnson Split
Charles R. Goulding and Arianna Coger look at how 3D technology usage could increase at J&J.